European Heart Journal Supplements

Article	Citations
Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review	50
Long COVID: long-term effects?	38
What do we do about atrial high rate episodes?	36
Left ventricular unloading and the role of ECpella	32
Atrial fibrillation in low- and middle-income countries: a narrative review	29
Lipoprotein(a) and PCSK9 inhibition: clinical evidence	24
Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies	24
Sympathetic activation in heart failure	23
Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal	22
Atrial fibrillation: villain or bystander in vascular brain injury	22
Coagulopathy and COVID-19	21
The metaverse in medicine	19
The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction	19
Concomitant diabetes with atrial fibrillation and anticoagulation management considerations	18
Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications	17
Infective endocarditis and neurologic events: indications and timing for surgical interventions	17
The impact of COVID-19 and COVID vaccination on cardiovascular outcomes	17
Back to the future: DCB use instead of DES for the treatment of complex, native coronary artery disease	16
Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation	16
Stress Echo 2030: the new ABCDE protocol defining the future of cardiac imaging	15
Escalation and de-escalation of mechanical circulatory support in cardiogenic shock	15
Stroke prevention in atrial fibrillation: comparison of recent international guidelines	14
COVID-19: patients with stroke or risk of stroke	13
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?	13
Influenza and cardiovascular disease pathophysiology: strings attached	12

What can health systems learn from COVID-19?	12
Anti-inflammatory therapy in ischaemic heart disease: from canakinumab to colchicine	12
ANMCO POSITION PAPER: Role of intra-aortic balloon pump in patients with acute advanced heart failure and cardiogenic shock	12
Intensive care unit management of percutaneous mechanical circulatory supported patients: the role of imaging	12
The omics of channelopathies and cardiomyopathies: what we know and how they are useful	12
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis	12
Treatment of amyloidosis: present and future	12
The treatment of amyloidosis is being refined	12
May Measurement Month 2019: results of blood pressure screening from 47 countries	11
Atrial fibrillation and stroke prevention: state of the art—epidemiology and pathophysiology: new risk factors, concepts and controversies	11
Surprises in cardiology: efficacy of gliflozines in heart failure even in the absence of diabetes	10
Is physical activity always good for you? The physical activity paradox	10
Current and future use of neuromodulation in heart failure	10
Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation	10
Neuromodulation devices for heart failure	10
Time is brain: timing of revascularization of brain arteries in stroke	10
Myths to debunk: the non-compacted myocardium	10
Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease	10
Severe aortic stenosis in the young, with or without bicuspid valve: is transcatheter aortic valve implantation the first choice?	10
Aortic and mitral bioprosthetic valve dysfunction: surgical or percutaneous solutions?	10
Scarring/arrhythmogenic cardiomyopathy	10
Clinical and radiological factors predicting stroke outcome after successful mechanical intervention in anterior circulation	9
Advanced remote care for heart failure in times of COVID-19 using an implantable pulmonary artery pressure sensor: the new normal	9
The ‘dreaded PFO’: anatomical and functional features of high risk for stroke	9
The myocardial bridge: incidence, diagnosis, and prognosis of a pathology of uncertain clinical significance	9
Electrical storm management in structural heart disease	9
Weaning from Impella and mobilization of Impella patients	9
The value and limitations of new oral anticoagulant plasma level assessments	9
Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging	8
Renal arteries denervation with second generation systems: a remedy for resistant hypertension?	8
Impact of the COVID-19 pandemic: a perspective from industry	8
Left bundle branch area pacing results in more physiological ventricular activation than biventricular pacing in patients with left bundle branch block heart failure	8
Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure	8
Getting ahead of the game: in-hospital initiation of HFrEF therapies	8
Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia	8
The path of transcatheter aortic valve implantation: from compassionate to low-risk cases	8
Myocardial infarction and viral triggers: what do we know by now?	8
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines	8
Sodium-glucose co-transporter 2 inhibitors in heart failure: an updated evidence-based practical guidance for clinicians	8
52nd ANMCO Congress Abstracts e-Posters	8
Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR	8
Evolution of interventional imaging in structural heart disease	7
May Measurement Month 2019: an analysis of blood pressure screening results from Nepal	7
The role of landiolol in the management of atrial tachyarrhythmias in patients with acute heart failure and cardiogenic shock: case reports and review of literature	7
Early risk of mortality, cardiovascular events, and bleeding in patients with newly diagnosed atrial fibrillation	7
ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)	7
Clinical application of personalized medicine: heart failure with preserved left ventricular ejection fraction	7
May Measurement Month 2019: an analysis of blood pressure screening results from Cameroon	7
The Brugada syndrome: pharmacological therapy	7
Echocardiography strain: why is it used more and more?	7

Pump flow setting and assessment of unloading in clinical practice	7
Optimized patient selection in high-risk protected percutaneous coronary intervention	6
Clinical implications of cardiac magnetic resonance imaging fibrosis	6
Takotsubo syndrome: more frequent in women, more dangerous in men	6
Cardiac magnetic resonance in ischemic cardiomyopathy: present role and future directions	6
New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran	6
The management of non-culprit coronary lesions in patients with acute coronary syndrome	6
Mitral valve prolapse with ventricular arrhythmias: does it carries a worse prognosis?	6
Does sacubitril/valsartan work in acute myocardial infarction? The PARADISE-AMI study	6
Acute rate control in atrial fibrillation: an urgent need for the clinician	6
Clinical impact of myocardial fibrosis in severe aortic stenosis	6
Managing vascular access and closure for percutaneous mechanical circulatory support	6
The natural history of hypertrophic cardiomyopathy	6
Long-term follow-up in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention	5
Sodium–glucose co-transporter 2 inhibitors for the treatment of cardio-renal syndrome	5
Concepts in cardiac oncology	5
Influenza vaccination in patients affected by diabetes	5
How effective is cryoablation in the treatment of atrial fibrillation?	5
COVID-19 and paediatric patient involvement (cardiovascular aspects)	5
Cardiac magnetic resonance-guided cardiac ablation: a case series of an early experience	5
P292 REDEFINING THE EPIDEMIOLOGY OF CARDIAC AMYLOIDOSIS. A SYSTEMATIC REVIEW OF SCREENING STUDIES	5
May Measurement Month 2019: an analysis of blood pressure screening results from Hungary	5
ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with and without diabetes	5
Patient with heart failure: importance to treat valvular diseases	5
Cardioprotective shock management: monitoring and supportive therapies	5
Impact of the exposome on cardiovascular disease	5
Therapeutic uncertainties: first finding of atrial fibrillation in acute coronary syndrome	5
Advanced heart failure: from definitions to therapeutic options	5
May Measurement Month 2019: an analysis of blood pressure screening results from Spain	5
May Measurement Month 2019: an analysis of blood pressure screening results from Mexico	5
Atrial fibrillation in advanced renal failure: are there alternative solutions to warfarin-dicumarol?	5
What is the role of coronary revascularization to recover the contractility of the dysfunctional heart?	5
Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy	5
Atrial fibrillation and ischaemic heart disease: should we use acetylsalicylic acid beside anticoagulants?	5
Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction	5
Thrombosis in pre- and post-vaccination phase of COVID-19	5
Patient with valvular disease: evolving care patterns	5
Acute coronary syndromes and multivessel coronary artery disease	4
Blood pressure screening results from May Measurement Month 2019 in Vietnam	4
Causes of sudden death	4
Ablation of ventricular tachycardia in 2021	4
Iron deficiency in heart failure: diagnosis and clinical implications	4
Renal arteries denervation: from the treatment of resistant hypertension to the treatment of atrial fibrillation	4
P311 TAKOTSUBO CARDIOMYOPATHY RELATED TO MRNA SARS–COV2 VACCINE	4
Cardiac complications of COVID-19 vaccination: now we know more	4
Differential utilization of Impella devices, extracorporeal membrane oxygenation, and combined therapies as escalation and de-escalation strategies	4
Trends beyond the new normal: from remote monitoring to digital connectivity	4
New and old echographic parameters in heart failure	4
Focus on arrhythmogenic right ventricular cardiomyopathy	4
The new in anticoagulation: factor XI inhibitors	4
ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosis	4
Left atrial appendage occlusion in COVID-19 times	4
Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy	4
The role of cardiologists on the stroke unit	4
May Measurement Month 2019: an analysis of blood pressure screening results from Nigeria	4
Chronic heart failure: the role of di vericiguat	4
Autopsy and sudden death	4
What connection is there between intestinal microbiota and heart disease?	4
Atrial fibrillation and sympatho–vagal imbalance: from the choice of the antiarrhythmic treatment to patients with syncope and ganglionated plexi ablation	4
Update on supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease according to the LIRA method	4
May Measurement Month 2019: an analysis of blood pressure screening results from South Africa	4
Cardiac resynchronization therapy: present and future	4
Vaccines and cardiovascular outcomes: lessons learned from influenza epidemics	4
May Measurement Month 2019: an analysis of blood pressure screening results from Italy	4
Electrocardiogram in arrhytmogenic cardiomyopathy	4
Monitoring MCS patients on the intensive care unit: integrating haemodynamic assessment, laboratory data, and imaging techniques for timely detection of deterioration and recovery	4
May Measurement Month 2019: an analysis of blood pressure screening results from Republic of the Congo	4
Alternative atrial pacing site to improve cardiac function: focus on Bachmann’s bundle pacing	4
May Measurement Month 2019: an analysis of blood pressure screening results from Saudi Arabia	4
Is there a relationship between blood pressure values and dementia?	4
Less sodium and more potassium to reduce cardiovascular risk	4
Triggers, characteristics, and hospital outcome of patients with Takotsubo syndrome: 10 years experience in a large university hospital centre	4
Empagliflozin in heart failure with preserved ejection fraction: first success in mission impossible	4
Spontaneous coronary artery dissection: an unpredictable event	4
Prevention of stroke in patients with chronic coronary syndromes or peripheral arterial disease	4
Role of conduction system pacing in ablate and pace strategies for atrial fibrillation	4
May Measurement Month 2019: an analysis of blood pressure screening results from Kenya	4
ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation	4
Clinical results and mechanism of action of icosapent ethyl	4
The new type 2 diabetes mellitus therapy: comparison between the two classes of drugs GLPR (glucagon-like peptide receptor) agonists and SGLT2 (sodium–glucose cotransporter 2) inhibitors	4

Drug-coated balloon combined with drug-eluting stent for the treatment of coronary bifurcation lesions: insights from the HYPER study	4
Cardiac toxicity of chemotherapy for breast cancer: do angiotensin-converting enzyme inhibitors and beta blockers protect?	4
The link between influenza and myocardial infarction: vaccination protects	4
Dilemmas in cardiology: when to recanalize a chronic total occlusion	4
Fully automated measurement of aortic root anatomy using Philips HeartNavigator computed tomography software: fast, accurate, or both?	3
Post-infarct mitral insufficiency: when to resort to reparative surgery, when to the mitral clip	3
Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease	3
May Measurement Month 2019: an analysis of blood pressure screening results from Australia	3
Sodium-glucose co-transporter-2 drugs: are we sure they are useful only in the treatment of diabetes?	3
77 HELIOS-A: 18-MONTH EXPLORATORY CARDIAC RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS	3
Patient characteristics, treatment strategy, outcomes, and hospital costs of acute coronary syndrome: 3 years of data from a large high-volume centre in Central Europe	3
May Measurement Month 2019: an analysis of blood pressure screening results from the Democratic Republic of the Congo	3
Opportunistic screening for hypertension in the general population in Greece: International Society of Hypertension May Measurement Month 2019	3
When Brugada syndrome is at risk of sudden death: clinical and anatomical aspects	3
May Measurement Month 2019: an analysis of blood pressure screening results from Tunisia	3
Statins and age: is there a limit beyond which primary prevention is futile?	3
Representation matters: a call for inclusivity and equity in heart failure clinical trials	3
May Measurement Month 2019: an analysis of blood pressure screening results from Ghana-Sub-Saharan Africa	3
New prevention scenarios: polygenic risk	3
Treatment in patients with severe asymptomatic aortic stenosis: is it best not to wait?	3
ANMCO POSITION PAPER: Timing of coronary angiography in non-ST-segment elevation acute coronary syndromes	3
The electrocardiogram in non-ischaemic-dilated cardiomyopathy	3
Old unsolved problems: when and how to treat silent ischaemia	3
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy	3
May Measurement Month 2019: an analysis of blood pressure screening results from Poland	3
New insights from the MESA study: increased high-sensitivity troponins as a cardiovascular risk factor	3
Personalized vascular healthcare: insights from a large international survey	3
Management of bleeding in patients on direct oral anticoagulants in emergency department: where we are and where we are going	3
Cardiovascular prevention: Mediterranean or low-fat diet?	3
Chronic ischaemic heart disease and rivaroxaban: which patients derive the greatest benefit?	3
The many NOs to the use of Class IC antiarrhythmics: weren’t the guidelines too strict?	3
The Brugada syndrome: risk stratification	3
Pacing of the specialized His–Purkinje conduction system: ‘back to the future’	3
Heart failure therapy: the fifth card	3
May Measurement Month 2019: an analysis of blood pressure screening results from Lebanon	3
The value of the 12-lead electrocardiogram in the prediction of sudden cardiac death	3
Is drinking wine in moderation good for health or not?	3
Computed tomography to replace invasive coronary angiography? The DISCHARGE trial	3
544 Two cases of constrictive pericarditis temporally associated with mRNA-1273 COVID-19 vaccination	3
Prevention of chemotherapy-induced left ventricular dysfunction	3
The new 2023 ESC guidelines for the management of cardiomyopathies: a guiding path for cardiologist decisions	3
Pre-hospital delay, clinical characteristics, angiographic findings, and in-hospital mortality in young and middle-aged adults with acute coronary syndrome: a single-centre registry analysis	3
Italian Association of Hospital Cardiologists Position Paper ‘Gender discrepancy: time to implement gender-based clinical management’	3
May Measurement Month 2019: an analysis of blood pressure screening results from the United Kingdom and Republic of Ireland	3
May Measurement Month 2019: an analysis of blood pressure screening results from India	3
Therapy of Type 2 diabetes: more gliflozines and less metformin?	3
May Measurement Month 2019: an analysis of blood pressure screening results from China	3
May Measurement Month 2019: an analysis of blood pressure screening results from Korea	3
Recurrent pericarditis is less scary: the new therapeutic solutions	3
Implantable ventricular assistance systems (VAD) as a bridge to transplant or as ‘destination therapy’	3
Acute coronary syndromes: hospital management of dyslipidaemia with proprotein convertase subtilisin/kexin 9 inhibitors: time to act	3
308 Sex-related differences in long COVID-19 syndrome	3
May Measurement Month 2019: an analysis of blood pressure screening results from Malawi	3
May Measurement Month 2019: an analysis of blood pressure screening results from Slovenia	3
Challenges in ischaemic heart disease: not sleeping enough, not brushing your teeth, and skipping breakfast—three ways of increasing your risk of myocardial infarction?	3
Sudden cardiac death in ischaemic heart disease: coronary thrombosis or myocardial fibrosis?	3
P73 ANGIOGRAPHY–DERIVED INDEX OF MICROVASCULAR RESISTANCE (IMR–ANGIO) IN TAKOTSUBO SYNDROME	2
Late primary angioplasty (beyond 12 h): are we sure it should be avoided?	2
54 Sacubitril–valsartan (LCZ 696) improves longitudinal strain and ejection fraction in preclinical models treated with doxorubicin through NLRP3, MyD88, and pro-fibrotic chemokines	2
Challenges in cardiology: diagnosis of native and prosthetic valve endocarditis	2
Association between heart and dementia… keep an eye on the left atrium	2
Timing of cardioversion in atrial fibrillation: the sooner the better?	2
Digitally enabled cardiac rehabilitation following coronary revascularization: results from a single centre feasibility study	2
May Measurement Month 2018: an analysis of blood pressure screening results from Pakistan	2
P280 TEAMWORK IS SUCCESSFUL (1): FAVOUREABLE RE–CHALLENGE OF DOUBLE ANTI–HER2 TREATMENT IN SEVERE MYOCARDIAL DYSFUNCTION IN PATIENT WITH ADVANCED BREAST CANCER AND OCCULT TYPE II DIABETES	2
May Measurement Month 2019: an analysis of blood pressure screening results from Angola	2
How much does hypertension in pregnancy affect the risk of future cardiovascular events?	2
Defining the optimal revascularization strategy during protected high-risk procedures with Impella	2
Cardiac computed tomography: from anatomy to function	2
ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death	2
ANMCO POSITION PAPER: Use of sacubitril/valsartan in hospitalized patients with acute heart failure	2
ANMCO position paper: 2022 focused update of appropriate use criteria for multimodality imaging: aortic valve disease	2
May Measurement Month 2019: an analysis of blood pressure screening results from Bangladesh	2
201 Clinical presentation profiles and natural history of cardiac amyloidosis: long-term monocentric analysis (1990–2020)	2
New interventional solutions in calcific coronary atherosclerosis: drill, laser, shock waves	2
Stage-specific therapy for hypertrophic cardiomyopathy	2
Ventricular fibrillation ablation in cardiomyopathies and arrhythmic storm	2
Optimal bail-out and complication management strategies in protected high-risk percutaneous coronary intervention with the Impella	2
Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid	2
Heart failure and telemedicine: where are we and where are we going? Opportunities and critical issues	2
C64 UNMASKING THE PREVALENCE OF AMYLOID CARDIOMYOPATHY IN THE REAL WORLD: RESULTS FROM PHASE 2 OF AC–TIVE STUDY, AN ITALIAN NATIONWIDE SURVEY	2
‘Use of lipid-lowering therapy: the guidelines, the drugs or the patient?’	2
Present and future of coronary risk assessment	2
The PACMAN-AMI trial: a revolution in the treatment of acute coronary syndromes	2
Impact of myocardial revascularization on long-term outcomes in a nationwide cohort of first acute myocardial infarction survivors	2
May Measurement Month 2019: an analysis of blood pressure screening results from Colombia	2
Procedures for chronic total occlusion: when are they recommended and when not	2
P357 THE MANAGEMENT OF CHOLESTEROL LEVEL CONTROL WITH LIPID–LOWERING DRUGS IN ITALIAN CLINICAL PRACTICE: FINDINGS FROM THE STREAM (SUPPORTING WITH THE REAL–WORLD EVIDENCE THE ASSESSMENT OF MEDICINES A	2
The revolution project: replacing coronary artery angiography with coronary computed tomography with functional evaluation	2
May Measurement Month: results of 12 national blood pressure screening programmes between 2017 and 2019	2
P149 AN UNUSUAL CASE OF CARDIAC TAMPONADE AND ST–SEGMENT ELEVATION MYOCARDIAL INFARCTION	2
Echocardiography in cardioembolic stroke prevention	2
Transcatheter ablation in patients with Brugada syndrome	2
Device closure for patent foramen ovale in patients with cryptogenic stroke: which patients should get it?	2
On site cardiac surgery for structural heart interventions: a fence to mend?	2